A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants
about
Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitorsCurrent perspectives on HIV-1 antiretroviral drug resistanceStructure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants.Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance.Identification of Binding Mode and Prospective Structural Features of Novel Nef Protein Inhibitors as Potential Anti-HIV Drugs.Low Frequency of Drug-Resistant Variants Selected by Long-Acting Rilpivirine in Macaques Infected with Simian Immunodeficiency Virus Containing HIV-1 Reverse Transcriptase.Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.Structure-enhanced methods in the development of non-nucleoside inhibitors targeting HIV reverse transcriptase variants.Novel fused pyrimidine and isoquinoline derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2016105532A1, WO2016105534A1 and WO2016105564A1.Rilpivirine and Doravirine Have Complementary Efficacies Against NNRTI-Resistant HIV-1 Mutants.Dynamic features of apo and bound HIV-Nef protein reveal the anti-HIV dimerization inhibition mechanism.
P2860
Q26777448-09D054FD-8F24-406F-9707-3380AF79C5C6Q26852626-474A022B-E857-44C9-B3B8-FBCF1638D12BQ35228851-003E82C0-D428-416A-AF60-D78535BC6FD8Q36146704-1502DBA6-FD84-4BD6-B3A4-5C4C6AF64748Q36226323-8A6BF024-BE6F-4DEF-97D4-6E2799A52286Q36290753-A632E4C3-5BF5-4C5F-85AB-A9AC27781C93Q36583683-27E1E32D-AC26-4BB9-B900-EC6BE0B51FD2Q38620336-14608136-FA8A-4DFF-8C76-3F95A4FD8DF3Q39169967-9C99EF02-C8D6-4FC5-A223-C2E9503DA506Q39813922-E32E9E33-2F30-4139-8431-15135A141E66Q41380529-DF30E0A7-94C1-4A9F-AD0C-DFD2028005B8
P2860
A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A comparison of the ability of ...... reverse transcriptase mutants
@ast
A comparison of the ability of ...... reverse transcriptase mutants
@en
A comparison of the ability of ...... reverse transcriptase mutants
@nl
type
label
A comparison of the ability of ...... reverse transcriptase mutants
@ast
A comparison of the ability of ...... reverse transcriptase mutants
@en
A comparison of the ability of ...... reverse transcriptase mutants
@nl
prefLabel
A comparison of the ability of ...... reverse transcriptase mutants
@ast
A comparison of the ability of ...... reverse transcriptase mutants
@en
A comparison of the ability of ...... reverse transcriptase mutants
@nl
P2093
P2860
P356
P1433
P1476
A comparison of the ability of ...... reverse transcriptase mutants
@en
P2093
Barry C Johnson
Craig J Thomas
David J Maloney
Disha Patel
Ganesha Rai
Gary T Pauly
Heather L Baker
Joel P Schneider
Joseph D Bauman
Kalyan Das
P2860
P2888
P356
10.1186/1742-4690-9-99
P577
2012-12-05T00:00:00Z
P5875
P6179
1041009839